Sign in →

Test Code VIP Vasoactive Intestinal Polypeptide, Plasma

Additional Codes

Epic Ordering Code LAB3040120
NBS code LBC01019
Service code 36940

Reporting Name

Vasoactive Intestinal Polypeptide,P

Specimen Type

Plasma EDTA


Ordering Guidance


 



Specimen Required


Supplies: Sarstedt Aliquot Tube, 5 mL (T914)

Collection Container/Tube: Lavender top (EDTA)

Submission Container/Tube: Plastic vial

Specimen Volume: 1 mL

Collection Instructions: Centrifuge and aliquot plasma into a plastic vial. Freeze immediately.


National University Hospital-Singapore Note:

NUH Outreach Laboratories:
Specimen Requirements
Submit the following:
Container: Purple Top
Processing Requirements
Centrifuge and aliquot plasma into a Mayo plastic tube. Freeze immediately.
Specimen type: Plasma
Volume: 1 mL
Storage/transport requirements: Frozen

Forms

If not ordering electronically, complete, print, and send an Oncology Test Request (T729) with the specimen.

Specimen Minimum Volume

0.55 mL

Specimen Stability Information

Specimen Type Temperature Time
Plasma EDTA Frozen 90 days

Reject Due To

Gross hemolysis Reject
Gross lipemia Reject
Gross icterus OK

Method Name

Enzyme-Linked Immunosorbent Assay (ELISA)

Day(s) Performed

Monday, Thursday

Report Available

2 to 4 days
National University Hospital-Singapore Note:

Please note that this is a referral test requiring transport to the external testing facility and an additional 3-5 days is required.

Reference Values

<86 pg/mL

Performing Laboratory

Mayo Clinic Laboratories in Rochester

Useful For

Detecting vasoactive intestinal polypeptide-producing tumors in patients with chronic diarrheal diseases

CPT Code Information

84586

LOINC Code Information

Test ID Test Order Name Order LOINC Value
VIP Vasoactive Intestinal Polypeptide,P 3125-2

 

Result ID Test Result Name Result LOINC Value
8150 Vasoactive Intestinal Polypeptide,P 3125-2

Secondary ID

8150

Test Classification

This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.
National University Hospital-Singapore Additional Information:

Last updated 17/08/2026